Curcumin Collaborative Project

2010

This collaborative project will identify and characterize novel curcumin-like derivatives for the treatment and prevention of Alzheimer’s disease. The purpose of the study is to develop means of overcoming obstacles to rapid breakdown and creating methodologies for precisely delivering curcumin derivatives to appropriate locations within the brain.

Drug Discovery Drug Screening Projects Rudy Tanzi William Klunk

Development of a Multicellular Brain Model to Study Brain-Vascular-Peripheral Immune Cells Crosstalk in Alzheimer’s Disease

Weiming Xia, | 2021

Alzheimer’s Disease Drug Discovery and Development Consortium: Blocking Synaptotoxicity in Alzheimer’s Three-Dimensional Models

Stephen T.C. Wong, | 2021

Alzheimer’s Disease Drug Discovery and Development Consortium: Uncovering the Molecular Mechanism of Selected Drug Candidates Derived from Systematic Alzheimer’s Drug Repositioning

Hermann Steller, | 2021

Stimulating Synaptic Proteasome Activity for the Treatment of Alzheimer’s Disease

Doo Yeon Kim, Luisa Quinti, | 2021

Alzheimer’s Disease Drug Discovery and Development Consortium: High-Throughput Drug Screening for Alzheimer’s Disease Using Three-Dimensional Human Neural Culture Systems

Seiko Ikezu, Tsuneya Ikezu, | 2021

Targeting Microglial TSG101 for Synaptic Protection and Cognitive Enhancement in Alzheimer’s Disease

Ana Griciuc, | 2021

Alzheimer’s Disease Drug Discovery and Development Consortium: Modulating CD33 Function and Neuroinflammation as a Therapeutic Approach for Alzheimer’s Disease

Li Gan, Subhash Sinha, | 2021

Development of Human cGAS Inhibitors to treat Alzheimer’s Disease

Curcumin Collaborative Project

Funding to Date

Focus

Researchers

Related Content: